๐ŸŽ Black Friday: up to 50% off of annual plans
BenQ Medical Technology Corporation (TPEX:4116)
Taiwan flag Taiwan ยท Delayed Price ยท Currency is TWD
38.55
-2.20 (-5.40%)
Nov 20, 2026, 1:24 PM CST

BenQ Medical Technology Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
5,3995,2544,7674,5434,3771,465
Revenue Growth
3.85%10.21%4.94%3.80%198.82%4.55%
Gross Profit
1,7521,6901,4481,3441,247512.28
Operating Income
273.46342.42333.02365.44350.2646.46
Net Income
760.7678.17104.83114.58180.2428.84
Earnings Per Share
16.511.752.342.564.020.65
EPS Growth
759.84%-25.21%-8.59%-36.32%521.20%-53.44%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Medical Services
4,3873,7863,5323,352481.86
Adjustment and Elimination
-74.87-56.79-20.52-65.59-35.9
R&D and Manufacturing Department
941.421,0391,0321,0901,019
Total
5,2544,7674,5434,3771,465

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,3611,1881,1461,1541,167419.19
Total Debt
1,2611,9891,9061,5721,117491.75
Net Cash (Debt)
99.77-800.37-760.13-418.1550.19-72.55
Net Cash Growth
------
Net Cash Per Share
2.17-17.87-16.96-9.331.12-1.62

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
442.8358.75222.22442.35482.84121.35
Capital Expenditures
-60.13-93.91-170.09-133.47-76.89-30.26
Free Cash Flow
382.67264.8452.14308.88405.9591.09
Free Cash Flow Growth
65.79%407.99%-83.12%-23.91%345.66%-20.84%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
32.45%32.16%30.38%29.58%28.50%34.98%
Operating Margin
5.07%6.52%6.98%8.04%8.00%3.17%
Pretax Margin
19.57%6.37%6.91%6.83%7.21%4.22%
Profit Margin
14.09%1.49%2.20%2.52%4.12%1.97%
FCF Margin
7.09%5.04%1.09%6.80%9.28%6.22%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
2.0002.0001.6502.0002.1000.500
Dividend Per Share Growth
21.21%21.21%-17.50%-4.76%320.00%-50.00%
Dividend Yield
5.19%4.54%3.50%3.13%3.28%1.51%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
2.3325.1420.0724.8915.8251.30
Forward PE
-32.8332.8332.8332.8332.83
P/FCF Ratio
4.497.4240.359.237.0316.24
PS Ratio
0.320.370.440.630.651.01